The FDA has approved finerenone (Kerendia, Bayer) for the treatment of adults with chronic kidney disease (CKD) associated with type 2 diabetes.
Megan M. Pantos, PharmD
Advertisement
Articles by Megan M. Pantos, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
3
What TrumpRx Means for Independent Pharmacies and Their Patients
4
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
5
